To encourage strong, good-faith dialogue about troublesome points, STAT publishes chosen Letters to the Editor acquired in response to First Opinion essays. As...
Orelabrutinib Plus FCG Generates Speedy Molecule Remissions in CLLOrelabrutinib together with fludarabine, cyclophosphamide, and obinutuzumab (Gazyva; FCG) produced speedy molecular remissions that deepened...
